CEBPA and prostate cancer: In view of very low level of constitutional expression of C/EBPα protein in the LNCaP cells, a widely used prostate cancer cell line that expresses AR and PSA, exogenous C/EBPα was expressed by use of a retrovirus system and two pooled clones of LNCaP cells with stable expression of C/EBPα were established.